Brief: Adverum Biotechnologies Appoints Jason L. Mitchell As Chief Commercial Officer As It Prepares To Initiate Pivotal Program
16/10/2024 13:00
Oct 16 (Reuters) - Adverum Biotechnologies Inc ADVM.O :
* ADVERUM BIOTECHNOLOGIES APPOINTS JASON L. MITCHELL AS
CHIEF
COMMERCIAL OFFICER AS IT PREPARES TO INITIATE PIVOTAL PROGRAM
Source text for Eikon: ID:nGNX157R8p
Further company coverage: ADVM.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Adverum Biotechnologies
See all newsNASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 07:50 PM
Brief: Adverum Reminds Stockholders To Tender Their Shares Into The Offer By Lilly
Brief: Adverum Biotechnologies Inc - Are-Nc Region No. 21 Llc Terminates Certain Lease Agreement With Adverum Biotechnologies - SEC Filing
Eli Lilly bets on eye care with buyout of gene therapy developer Adverum (updated)